Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acute kidney injury in very low birth weight preterm neonates treated with caffeine
PACTR202609869984135Recruiting
- Sponsor
- Faculty of Medicine, Menoufia University
- Start
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of caffeine in apnea of prematurity (AOP) (2 arms), sponsored by Faculty of Medicine, Menoufia University. Primary endpoint: Correlation between urinary beta-2 microglobulin and acute kidney injury. Started Aug 2026; status: recruiting.
02
Drugs
caffeine
03
Conditions
apnea of prematurity (AOP)
Beyond the preview
Go deeper on PACTR202609869984135.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202609869984135.